Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,446 |
Gross Profit | -494 | -490 | 2,957 | |
EBITDA | -78,835 | -22,737 | -22,584 | -12,340 |
EBIT | -79,335 | -23,231 | -23,074 | -12,829 |
Net Income | -76,616 | -21,854 | -21,398 | -11,296 |
Net Change In Cash | 0 | 0 | 0 | 3,446 |
Free Cash Flow | -15,117 | -17,659 | -12,539 | -6,314 |
Cash | 48,413 | 57,024 | 42,847 | 169,681 |
Basic Shares | 41,879 | 38,631 | 36,208 | 34,441 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,958 | -2,210 | -2,207 | -2,194 |
EBITDA | -37,030 | -21,857 | -28,703 | -29,995 |
EBIT | -38,988 | -24,067 | -30,910 | -32,189 |
Net Income | -38,988 | -20,319 | -29,561 | -15,375 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 28,491 | |||
Free Cash Flow | -24,940 | -20,794 | -27,792 | -25,231 |
Cash | 169,681 | 14,602 | 21,304 | 49,224 |
Basic Shares | 16,492 | 8,397 | 5,318 | 4,174 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.83 |
2024-06-30 | -$0.57 |
2024-03-31 | -$0.59 |
2023-12-31 | -$0.33 |
